Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.
about
A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake InhibitorSeizures associated with therapeutic doses of venlafaxine and trimipramine.Managing depressive disorders in patients with epilepsy.Elevated serotonergic signaling amplifies synaptic noise and facilitates the emergence of epileptiform network oscillations.Shared mechanisms of antidepressant and antiepileptic treatments: drugs and devices.Rats bred for susceptibility to depression-like phenotypes have higher kainic acid-induced seizure mortality than their depression-resistant counterpartsEpileptogenic drugs: a systematic review.Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?Fluoxetine overdose-induced seizureThe GABAergic Hypothesis for Cognitive Disabilities in Down SyndromeSerotonin Regulates the Firing of Principal Cells of the Subiculum by Inhibiting a T-type Ca2+ Current.The Impact of Psychoactive Drugs on Seizures and Antiepileptic Drugs.A stroke patient with a non-convulsive status epilepticus during citalopram therapy.The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice.Sleep-related epilepsy in a Long-Evans hooded rat model of depression.[Serotonin prevents temporal lobe epilepsy by inhibiting bursting neurons from the subiculum].Depressive Disorders: Major Depressive Disorder and Persistent Depressive Disorder
P2860
Q24563250-4B0E533D-1DE5-4274-8AC9-13FB28833E8CQ31805799-646C1110-DF7C-442F-9CDD-4F0FE0025F9EQ34068952-288FCF91-35D8-4733-BD0C-44BE1AAC34ADQ34519135-E3370274-1E68-4A32-97F8-D6652CAF8B31Q35757922-54973579-1DEA-40F8-A025-978C6A31D9B9Q35925318-D5B7D042-EF4E-4524-B921-A445E0DAECF1Q36453297-8523DE67-481C-42DB-B7EC-3DEA72358AB8Q36709214-891AF483-0A59-4B7D-A18E-80435E5C7FB3Q37166918-781DBA48-71A1-481A-AA9A-4D70CCFD8B37Q37683060-6F427459-AC1E-4FE7-9596-151E6EE88C67Q37683267-2B40E6E1-5BD6-46A7-B3D0-596CA394F9C2Q38868459-417575B3-EE0E-4DA9-9415-BAECBCB78281Q43977287-79FAA229-3EF8-49B4-817E-2D870746EEDBQ46624943-85E66A99-029F-4755-8E88-BFC5C0941788Q48267647-D090DAD7-C674-4739-AFA0-915677660B2CQ49845893-08125A4E-D2AE-47C2-AB78-4EBD1A4F9391Q57703141-3A185035-462B-4D40-A3A3-8FB23B77AF37
P2860
Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.
@ast
Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.
@en
type
label
Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.
@ast
Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.
@en
prefLabel
Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.
@ast
Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.
@en
P2093
P2860
P1433
P1476
Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.
@en
P2093
P2860
P304
P356
10.1111/J.1528-1157.1999.TB00885.X
P478
40 Suppl 10
P577
1999-01-01T00:00:00Z